Tocilizumab in Lung Transplantation
Condition:   Lung Transplant Interventions:   Drug: Tocilizumab;   Drug: Placebo for Tocilizumab Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 12, 2023 Category: Research Source Type: clinical trials

A Trial to Evaluate an HIV Envelope Trimer, N332-GT5 gp140, Adjuvanted With SMNP in Adult Participants Without HIV
Condition:   HIV Interventions:   Biological: N332-GT5 gp140 (IM, Bolus);   Biological: N332-GT5 gp140 (IM, Fractioned);   Biological: N332-GT5 gp140 (SC, Bolus);   Biological: N332-GT5 gp140 (SC, Fractioned);   Biological: SMNP (IM, Bolus);   Biological: SMNP (IM, Fractioned);   Biological: SMNP (S C, Bolus);   Biological: SMNP (SC, Fractioned) Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   National Institutes of Health (NIH);   Department of Health and Human Services Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 12, 2023 Category: Research Source Type: clinical trials

Pausing Antiretroviral Treatment Under Structured Evaluation
Condition:   HIV-1-infection Interventions:   Drug: 3BNC117-LS-J;   Drug: 10-1074-LS-J;   Drug: Placebo for 3BNC117-LS-J;   Drug: Placebo for 10-1074-LS-J Sponsors:   AIDS Clinical Trials Group;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 11, 2023 Category: Research Source Type: clinical trials

Phase I Safety Study of B/HPIV3/S-6P Vaccine Via Nasal Spray in Adults
Condition:   SARS-CoV-2 Infection Intervention:   Biological: B/HPIV3/S-6P Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Johns Hopkins Bloomberg School of Public Health;   National Institutes of Health (NIH) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 7, 2023 Category: Research Source Type: clinical trials